1989
DOI: 10.1016/0305-4179(89)90007-7
|View full text |Cite
|
Sign up to set email alerts
|

Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
110
0

Year Published

1992
1992
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 247 publications
(110 citation statements)
references
References 11 publications
0
110
0
Order By: Relevance
“…At present, only ex vivo retroviral delivery to autologous keratinocytes followed by skin grafting has thus far led to successful correction of the JEB subtype in the clinical setting (Mavilio et al, 2006). As a main source of type VII collagen-producing cells in vivo (Burgeson, 1993), autologous cultured keratinocytes have been widely used for the permanent coverage of severe fullthickness burns with further indication of the long-term reepithelialization of the grafted sites (De Luca et al, 1989;Pellegrini et al, 1998). Moreover, earlier preclinical studies showed successful correction of the RDEB phenotype using ex vivo gene therapy and keratinocytes modified with either viral (Chen et al, 2002;Gache et al, 2004) or nonviral (OrtizUrda et al, 2002) vectors.…”
Section: Discussionmentioning
confidence: 99%
“…At present, only ex vivo retroviral delivery to autologous keratinocytes followed by skin grafting has thus far led to successful correction of the JEB subtype in the clinical setting (Mavilio et al, 2006). As a main source of type VII collagen-producing cells in vivo (Burgeson, 1993), autologous cultured keratinocytes have been widely used for the permanent coverage of severe fullthickness burns with further indication of the long-term reepithelialization of the grafted sites (De Luca et al, 1989;Pellegrini et al, 1998). Moreover, earlier preclinical studies showed successful correction of the RDEB phenotype using ex vivo gene therapy and keratinocytes modified with either viral (Chen et al, 2002;Gache et al, 2004) or nonviral (OrtizUrda et al, 2002) vectors.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, cultured epidermal are taken as a permanent coverage of wounds, and they are known as an epoch-making treatment for large burns for which an adequate skin replacement is complex to achieve 4,13 . However, usually acute burn patients have to wait for the growth of the epidermis once the epidermal culture requires almost one month.…”
Section: Introductionmentioning
confidence: 99%
“…In the literature, several authors have described the cultured epidermal allografts for freezing, expanding its availability and making your employment as a viable clinical alternative 3,5,6,13 . Thus, the cryopreservation of cultured epithelium has been a constant search topic in many centers worldwide 3,5,[13][14][15] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, although early reports of successful keratinocyte allograft transplantation 4,7 were supported by the finding that recipient blood group antigen expression was absent on epidermal cells at the allografted site and by the lack of stimulation of the mixed epidermal cell lymphocyte reaction between donor keratinocytes and recipient lymphocytes, 8 more recent investigations have failed to provide convincing evidence that the surviving grafted keratinocytes are of donor origin even though frank allograft rejection is not observed. [9][10][11][12][13] It is now well established that allografts may be rejected even in the absence of direct allopresentation (lack of professional donor antigen-presenting cells) via the indirect allopresentation pathway mediated by host antigen-presenting cells that infiltrate the graft within 2 weeks following transplantation and pick up donor alloantigens (especially MHC class I molecules (MHCI)), and present them to host T cells in the draining lymph nodes. These controversial results have highlighted the difficulties in establishing whether keratinocyte allografts can be used for more than a temporary skin covering.…”
Section: Introductionmentioning
confidence: 99%